Retatrutide Dosing# Retatrutide is administered as once-weekly subcutaneous injections with escalation from 0.5 mg to the target dose of 12 mg over multiple weeks
For patients seeking an acute intervention, whether for cognitive clarity, post-illness recovery, or performance enhancement, the IV route offers distinct advantages
With 5mL bacteriostatic water: Peptide mass: 50mg Bacteriostatic water: 5mL Concentration: 50mg 5mL = 10 mg/mL = 10,000 mcg/mL Peptide per unit (100-unit syringe): 10 mg 100 = 0.1 mg/unit = 100 mcg/unit If research protocol calls for 1000 mcg (1mg) per research unit: 1000 mcg 100 mcg/unit = 10 units on the syringe Total doses per vial at 1mg each: 50,000 mcg 1,000 mcg = 50 research doses Why GHK-Cu is supplied in 50mg vials rather than 10mg vials: because research GHK-Cu protocols typically use larger per-research-unit amounts, and a 10mg vial would only supply a few doses
Animal research has suggested that liraglutide may also increase the risk of certain malignancies, such as thyroid cancer, but clinical studies are less definitive and continue to investigate whether these effects may also occur in humans [26]
Oxalobacter formigenes colonization normalizes oxalate excretion in a gastric bypass model of hyperoxaluria